StonvexLoading…
StonvexStonvexStonvexCore line items from SLS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $1.00M | $7.60M | $1.90M |
Operating Income | $-37.87M | $-41.95M | $-25.29M | $-16.98M |
Net Income | $-37.34M | $-41.30M | $-20.70M | $-16.76M |
EPS (Diluted) | $-1.34 | $-2.13 | $-1.34 | $-2.11 |
Total Assets | $6.22M | $20.94M | $26.27M | $46.05M |
Total Liabilities | $14.20M | $16.09M | $5.93M | $18.09M |
Cash & Equivalents | $2.53M | $17.13M | $21.36M | $35.30M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 32.13M | 21.01M | 15.90M | 14.25M |